PD-1-deficient Tregs improved the symptoms of autoimmune pancreatitis in a mouse model (66), while in human glioblastoma tissues, Tregs expressing a high level of PD-1 had an exhausted phenotype and reduced immunosuppressive function (67). This evidence concerns the gene PDCD1 and glioblastoma.